mortality/aging
• mice die within 2 weeks of pIpC treatment
• however, transplantation with wild-type bone marrow rescues lethality
|
hematopoietic system
• pIpC-treated mice exhibit reduced GM- and GEMM-CFUs compared with control mice
|
• pIpC-treated mice exhibit spots of proliferating lymphoid cells unlike in control mice
|
• in pIpC-treated mice
|
• in pIpC-treated mice
|
• in pIpC-treated mice
|
• in pIpC-treated mice
|
• in pIpC-treated mice
|
• in pIpC-treated mice
|
• pIpC-treated mice exhibit reduced Lin-Sca-Kit+ cells compared with control mice
|
• in pIpC-treated mice
|
• pIpC-treated mice exhibit increased leukocyte apoptosis in bone marrow unlike control mice
|
liver/biliary system
pale liver
(
J:169944
)
• in pIpC-treated mice
|
immune system
• pIpC-treated mice exhibit spots of proliferating lymphoid cells unlike in control mice
|
• in pIpC-treated mice
|
• in pIpC-treated mice
|